Sagace Wealth Management LLC Purchases New Stake in Intuitive Surgical, Inc. $ISRG

Sagace Wealth Management LLC purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 473 shares of the medical equipment provider’s stock, valued at approximately $257,000.

A number of other institutional investors have also recently modified their holdings of ISRG. Norway Savings Bank raised its holdings in Intuitive Surgical by 53.4% during the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock worth $1,420,000 after purchasing an additional 910 shares during the last quarter. IronOak Wealth LLC. acquired a new position in Intuitive Surgical during the second quarter worth $1,099,000. Trust Co. of Oklahoma acquired a new position in Intuitive Surgical during the second quarter worth $363,000. Neville Rodie & Shaw Inc. raised its holdings in Intuitive Surgical by 11.9% during the second quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock worth $5,666,000 after purchasing an additional 1,110 shares during the last quarter. Finally, Sax Wealth Advisors LLC raised its holdings in Intuitive Surgical by 218.1% during the second quarter. Sax Wealth Advisors LLC now owns 2,456 shares of the medical equipment provider’s stock worth $1,334,000 after purchasing an additional 1,684 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the business’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director owned 739 shares of the company’s stock, valued at approximately $325,669.91. The trade was a 31.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares of the company’s stock, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 45,224 shares of company stock valued at $21,716,492. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Up 0.2%

Shares of NASDAQ:ISRG opened at $436.39 on Wednesday. The company has a market cap of $156.44 billion, a P/E ratio of 60.86, a P/E/G ratio of 4.58 and a beta of 1.61. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The business has a fifty day simple moving average of $456.92 and a 200-day simple moving average of $497.02.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the previous year, the business earned $1.78 earnings per share. The firm’s quarterly revenue was up 21.4% compared to the same quarter last year. Sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on ISRG shares. Evercore ISI reduced their price objective on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating for the company in a report on Tuesday, October 7th. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Truist Financial boosted their price target on Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 23rd. Mizuho lowered their price objective on Intuitive Surgical from $570.00 to $520.00 and set a “neutral” rating for the company in a research report on Tuesday. Finally, The Goldman Sachs Group lowered their price objective on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a research report on Wednesday, October 1st. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $585.71.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.